Highlights from INFN-MED

Slides:



Advertisements
Similar presentations
Copyright © 2013 SCKCEN MAX School - Frankfurt am Main – 1 st -2 nd October 2013 MYRRHA Multipurpose hYbrid Research Reactor for High-tech Applications.
Advertisements

The role of IRE in Nuclear Medicine The success story of a cooperation between South-Africa and Belgium Catherine Gernay Director IRE.
Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.
ECPM 2006, Nice, France, 2-4 November DESIGN STUDIES OF THE 300AMEV SUPERCONDUCTING CYCLOTRON FOR HADRONTHERAPY Mario Maggiore Laboratori Nazionali.
Computer Science AND DOCTORS Jolena Co Truong- 6 th period.
Academic Clinical Trial Do’s & Don’ts for Partnering with Pharma CCAF San Diego, CA April 14, 2014 J. Eric Bubbers, Ph.D.
January 2006 JINR SC Session Объединенный институт ядерных исследований Joint Institute for Nuclear Research JINR and Innovation Activities A.Ruzaev Международная.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Varian Medical Systems By KJ Neish. History ›Originally incorporated in 1948 as Varian Associates, Inc. ›Changed name to Varian Medical Systems, Inc.
TEKNOLOGI IKERTEGIA TECHNOLOGICAL RESEARCH CENTRE Dependable applications for DeSIRE (Pisa November 2002) A.R.Olano/Ikerlan
Giovanni Ciavola I3 EURONS-2 COMPLECS Town Meeting, Sept. 19th, 2007, Helsinki 1 INFN - GSI - GANIL - LPSC - JYFL - KVI CERN - ATOMKI- TSL - NIPNE - IKF-
The EMMA Project Rob Edgecock STFC Rutherford Appleton Laboratory & Huddersfield University *BNL, CERN, CI, FNAL, JAI, LPSC Grenoble, STFC, TRIUMF.
Strategic Technology Alliances Prasada Reddy Centre for Entrepreneurship University of Oslo, Norway.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
From Physics to Health applications: challenges and benefits Serbia Detector School, 13 September 2014 Manjit Dosanjh, CERN.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
Networked Audio Visual Systems and Home Platforms ADMIRE-P at Med-e-Tel 2005 April 6-8, Application of Video Technologies and Pattern Recognition.
Heavy Ion Accelerators for RIKEN RI Beam Factory and Upgrade Plans H. Okuno, et. al. (RIKEN Nishina Center) and P. Ostroumov (ANL) Upgrade Injector Low.
ICIS2015 in NY Y.HIGURASHI Y. Higurashi (RIKEN Nishina center) 1.Introduction RIKEN RIBF and RIKEN 28GHz SC-ECRIS 2.Emittance measurements 1.4D.
Ions for Health Initiative Nuclear Facility with Medical Applications INSTITUTUL NAŢIONAL de C&D PENTRU FIZICĂ şi INGINERIE NUCLEARĂ “HORIA HULUBEI” IFIN-HH.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
1 Report of PAC for Particle Physics T. Hallman Presented by P. Spillantini JINR Scientific Council Meeting June 3-4, 2004 Dubna, Russia.
Improvement of the Monte Carlo Simulation Efficiency of a Proton Therapy Treatment Head Based on Proton Tracking Analysis and Geometry Simplifications.
Giovanni Ciavola, JRA-07 ISIBHI JRA-07 Ion Sources for Intense Beams of Heavy Ions (ISIBHI) EURONS PCC Meeting, Groningen, Holland, December 2006.
EuCARD2  Third in a series of FP6/7 IAs on Accelerator R&D: Coordinated Accelerator Research in Europe(FP6) to coordinated by CEA - 22 partners.
Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
Jean-Marie Le Goff ETT Division meeting April ETT Education and Technology Transfer Division Technology Transfer Group Jean-Marie Le Goff.
Welcome !! to the CAoPAC Workshop Carsten P. Welsch.
Aims of the Workshop  EuCARD2  WP4: Applications of Accelerators  Past workshops  Future workshops  Plans  Aims of this workshop EuCARD-2 is co-funded.
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Implementation of a New Monte Carlo Simulation Tool for the Development of a Proton Therapy Beam Line and Verification of the related Dose Distributions.
JINR-CERN 5-years Partnership Program N.Russakovich 103-rd session of theJINR Scientific Council meeting JINR, Dubna, 21 February 2008.
Varian Medical Systems
HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,
Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Proton Radiation.
0 Ion Beam Facilities at KOMAC Chan Young Lee on behalf of KOMAC Chan Young Lee on behalf of KOMAC ICABU2014, November 12~14,
La Radiobiologia e la Fisica Medica in Gruppo V Valter Bonvicini INFN Trieste Workshop “La Radiobiologia in INFN”, Trento, 12 – 13 Maggio 2016.
Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Neutron Sources.
Plans and Activities at CERN
Biomedical Data Science for Precision Medicine
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Bioreactor Market to surpass.
  The University of Derby and its delivery partners have been awarded £7.5m of funding from the England European Regional Development Fund as part of the.
Design of a General Purpose I/O Controller for Particle Accelerators
Medical Applications Knowledge Transfer | Accelerating Innovation.
Introducing Knowledge CERN Dr. Zoe Lawson.
Towards a roadmap for collaborative R&D
BEAT_PRO Beam Tailoring and procedures optimization for clinical bnct
Injector Cyclotron for a Medical FFAG
Commissioning of the AISHA Ion Source at INFN-LNS
CLIC-Spain collaboration report
Radiopharmaceutical Production
Ion sources at LNS Slides from S. Gammino (INFN-LNS)
Presentation of the health pole Philippe Laniece (IMNC)
Better Science, Better Health: New Healthcare Models
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
CMS Goal of the experiment
Tbilisi Oncodipensary - Tbilisi Cancer Center
The Mysterious Magnetic Field
Ségolène Martin CEO/Kantify
What is the Fusion Industry Association?
The Hadrontherapy Geant4 advanced example
INFN and the ILC S. Bertolucci, INFN.
November 14, 2008 The meeting on RIKEN AVF Cyclotron Upgrade Progress report on activity plan Sergey Vorozhtsov.
Non-invasive Beam Position Monitor Research in HUST-PTF
CONT Meeting, 21 January
November 7, 2008 The meeting on RIKEN AVF Cyclotron Upgrade Progress report on activity plan Sergey Vorozhtsov.
Engage with running SAE projects
STRATEGIC ACTION IN HEALTH (AES)
NIST SBIR Program Manager 2017 National SBIR Conference May 17, 2017
Presentation transcript:

Highlights from INFN-MED the INFN strategic project for Medicine Areas of interest: Imaging Treatment Planning and Software projects Accelerator devices for Hadron Therapy BNCT Devices for Medical Diagnostics

Imaging: MAGIC-5 Project Fall out from the experience in the analysis of particle phyiscs experiments A highly competitive lung CAD (Computer Assisted Detection) has been developed, capable of speeding up diagnosis response in case of large screenings. Based on the development of different and complementary pattern recognition algorithms. Several recognitions at international level. Looking for an industrial partner to turn the prototype into a market product

(for instance Alzheimer Disease) Neuroimaging For the understanding and early diagnosis of pathophysiological mechanisms of neurodegenerative diseases (for instance Alzheimer Disease) Promising results work with the European Alzheimer’s Disease Consortium (EADC) Plans: Full MRI/PET combined analysis Development of more efficient computational tools WWW access to the clinical world Furthermore, side product from Magic-5: development of an innovative web service to manage Clinical Trials (diXit). Particularly useful for the experimentation in pharmacology

Treatment Planning System for therapy with C ions Fall out from the experience in software management, simulation tools, radiobiology and nuclear phsycs Collaboration Agreement with IBA . Development of .innovative system to be embedded in the “Oncology Information System” (OIS) in a configuration known under the name of MOSAIQ-RTP (Commercialized by Eleckta-CMS, controlled by IBA)

Status of development To Be Released October 2010 Plan To Be Released April 2010 Released April 2010 Released August 2010 To Be Released January 2011

Complete the design of a new Accelerator Source: MISHA Multicharged Ion Source for HAdrontherapy At CNAO center for hadrontherapy two ECR sources of the SUPERNANOGAN type (built by the Pantechnik company according to specifications set by INFN) are in operation. A further increase of accelerator reliability involves the improvement of the beam brightness, which can be achieved with the design and construction of a new ECR ion source, able to provide more than 600 eµA of C4+ with an emittance figure of 0.75π mm. mrad. The MISHA source will be a multipurpose device, providing enough versatility for future needs of the hadron therapy. The MISHA source has been designed on the basis of the expertise existing in INFN Labs (LNS and LNL, G. Ciavola et al.) Of interest for all accelerators for hadrontherapy

General layout of the MISHA source and of its Low Energy Maximum radial field 1.3 T Maximum axial field 2.5 T / 1.5 T Frequency 18 GHz + 17.8 GHz Maximum RF power 500 W + 500 W Maximum extraction field 50 kV Chamber diameter Ø 92 mm LHe free External Funding is being searched for (~1.5 M€ needed) General layout of the MISHA source and of its Low Energy Beam Transfer line

MID (under completion) Fall out from the experience in the development of high precision magnetic apparata in particle physics. First device capable of measuring the amount of Fe in human organs in a non invasive way (i.e. avoiding biopsy). From the experience of INFN Genova, co-financed and in under operation in Galliera Hospital (Genova).

ECORAD Fall out from the experience in the development of new particle detectors Now exploring Patent/Technology Transfer possibilities Resp.: R.Pani, INFN and Roma 1 Univ.

A first presentation of the project will take place in LNL/Padova New possibilities Design study for a facility to produce Radionuclides for Medicine using the new cyclotron at LNL LARAMED A first presentation of the project will take place in LNL/Padova at the end of November:

Relationships with CNAO and Healt Ministry Monitoring cooperation with CNAO foundation for hadron therapy in view of: MC Simulation Pre-clinic activity Treatment Plannig evolution Definition of collaboration agreement with Health Ministry for scientific exchange, relationship with industry in medical sector, cofinancing of activities of common interest